JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141003

MG-132, proteasome inhibitor

MG-132, proteasome inhibitor

5

(1 Review)

|

(55 Publications)

MG-132 (ab141003) is a proteasome inhibitor and contains the nodifications: N-terminal benzyloxycarbonyl; C-terminal aldehyde.  Molecular weight (MW) 475.6, Purity >98%.

- Proven performance: cited in over 50 publications
- Available in different sizes to fit your experimental needs

查看别名

mg 132, mg132, Z-Leu-leu-leu-al, DKFZp459C139, EC 3.4.25.1, HC7 I, LMPX, MB1, MGC104214, MGC118075, MGC134464, Macropain epsilon chain, Macropain subunit C7-I, Multicatalytic endopeptidase complex epsilon chain, Multicatalytic endopeptidase complex subunit C7 1, Multicatalytic endopeptidase complex subunit C7-I, PSB2_HUMAN, PSB5_HUMAN, PSMB2, PSMB5, PSX large multifunctional protease X, Proteasome (prosome, macropain) subunit beta type 2, Proteasome (prosome, macropain) subunit, beta type, 5, Proteasome beta 2 subunit, Proteasome beta 5 subunit, Proteasome catalytic subunit 3, Proteasome chain 6, Proteasome component C7-I, Proteasome epsilon chain, Proteasome subunit MB1, Proteasome subunit X, Proteasome subunit beta type-2, Proteasome subunit beta type-5, Proteasome subunit, beta-5

5 Images
Immunocytochemistry/ Immunofluorescence - MG-132, proteasome inhibitor (AB141003)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - MG-132, proteasome inhibitor (AB141003)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cell line from cervix adenocarcinoma) cells, treated with 2μM MG-132 (ab141003) for 18 hours or untreated, labeling SQSTM1 / p62 (phospho S349) with ab211324 at 1/100 dilution, followed by Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) secondary antibody at 1/200 dilution (green).

Confocal image showing cytoplasmic staining on HeLa cell line. The expression increased after treatment with 2μM MG-132 (ab141003) for 18 hours.

The nuclear counterstain is DAPI (blue).

Tubulin is detected with ab195889 (Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)) at 1/200 dilution (red).

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) at 1/1000 dilution.

Flow Cytometry (Intracellular) - MG-132, proteasome inhibitor (AB141003)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - MG-132, proteasome inhibitor (AB141003)

Flow cytometric analysis of 4% paraformaldehyde-fixed HeLa (Human epithelial cell line from cervix adenocarcinoma) cells, treated with 2μM MG-132 (ab141003) for 18 hours (red) or untreated (green), labeling SQSTM1 / p62 (phospho S349) with ab211324 at 1/500 dilution compared with a rabbit monoclonal IgG isotype control (ab172730; black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (Alexa Fluor® 488) at 1/2000 dilution was used as the secondary antibody.

Immunocytochemistry/ Immunofluorescence - MG-132, proteasome inhibitor (AB141003)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - MG-132, proteasome inhibitor (AB141003)

ab62352 staining Nrf2 in untreated HeLa cells (top panel) and treated HeLa cells (bottom panel). Cells were treated with 2μM of MG-132 for 18 hours (ab141003). The cells were fixed with 4% paraformaldehyde (10 min) then permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab62352 at 1μg/ml concentration and ab7291 (Mouse monoclonal to alpha Tubulin) at 1/1000 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat secondary antibody to rabbit IgG (Alexa Fluor® 488) (ab150081) at 2μg/ml (shown in green) and a goat secondary antibody to mouse IgG (Alexa Fluor® 594) (ab150120) at 2μg/ml (shown in red). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems TCS SP8).

Immunoprecipitation - MG-132, proteasome inhibitor (AB141003)
  • IP

Lab

Immunoprecipitation - MG-132, proteasome inhibitor (AB141003)

SQSTM1 / p62 (phospho S349) was immunoprecipitated from 0.35 mg of HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate treated with 2μM MG-132 (ab141003) for 18h with ab211324 at 1/30 dilution.

Western blot was performed from the immunoprecipitate using ab211324 at 1/1000 dilution.

VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.

Lane 1 : HeLa treated with 2μM MG-132 (ab141003) for 18h whole cell lysate, 10 μg (Input).
Lane 2 : ab211324 IP in HeLa treated with 2μM MG-132 (ab141003) for 18h whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab211324 in HeLa treated with 2μM MG-132 (ab141003) for 18h whole cell lysate.

Blocking and dilution buffer : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-SQSTM1 / p62 (phospho S349) antibody [EPR20451] (<a href='/products/primary-antibodies/sqstm1-p62-phospho-s349-antibody-epr20451-ab211324'>ab211324</a>)

Predicted band size: 47 kDa

false

Exposure time: 10s

Chemical Structure - MG-132, proteasome inhibitor (AB141003)
  • Chemical Structure

Lab

Chemical Structure - MG-132, proteasome inhibitor (AB141003)

2D chemical structure image of ab141003, MG-132, proteasome inhibitor

关键信息

CAS 号

133407-82-6

纯度

>98%

形式

Solid

form

分子量

475.6 Da

分子式

C<sub>2</sub><sub>6</sub>H<sub>4</sub><sub>1</sub>N<sub>3</sub>O<sub>5</sub>

PubChem

462382

属性

Synthetic

溶解度

Soluble in DMSO to 100 mM but unstable for prolonged periods.

Soluble in ethanol to 100 mM.

生化试剂名称

Z-Leu-leu-leu-al

生物学描述

LLL (Modifications: N-terminal benzyloxycarbonyl; C-terminal aldehyde)

经典 SMILES

CC(C)CC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCC1=CC=CC=C1

同分异构的 SMILES

CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1

InChi

InChI=1S/C26H41N3O5/c1-17(2)12-21(15-30)27-24(31)22(13-18(3)4)28-25(32)23(14-19(5)6)29-26(33)34-16-20-10-8-7-9-11-20/h7-11,15,17-19,21-23H,12-14,16H2,1-6H3,(H,27,31)(H,28,32)(H,29,33)/t21-,22-,23-/m0/s1

InChiKey

TZYWCYJVHRLUCT-VABKMULXSA-N

IUPAC 名

benzyl N-[(2S)-4-methyl-1-[[(2S)-4-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate

性能和储存信息

运输条件
Ambient - Can Ship with Ice
推荐的短期储存条件
-20°C
推荐的长期储存条件
-20°C
储存信息
It is important to note that this is air sensitive and impurities can occur as a result of air oxidation|Store under desiccating conditions

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

Proteasome subunit beta type 2 or PSMB2 also known as PSMB5/MB1 is an essential component of the proteasome complex with a molecular weight of approximately 26 kDa. This subunit participates in the assembly of the 20S core protease complex important for protein degradation functions within cells. PSMB2 is ubiquitously expressed in various tissues reflecting its broad role in cellular homeostasis. It contributes to the active sites of the proteasome facilitating the breakdown of ubiquitinated proteins.
Biological function summary

The PSMB2 and PSMB5 subunits play a role in regulated protein degradation as part of the ATP-dependent 26S proteasome complex. This complex orchestrates the degradation of unneeded or damaged proteins by proteolysis a chemical reaction that breaks peptide bonds. PSMB2 aids in maintaining protein quality control and cellular regulation by processing peptides into smaller fragments for further degradation or presentation by MHC class I molecules. Its activity is essential for regulating numerous cellular processes including cell cycle control signal transduction and immune responses.

Pathways

The PSMB2 protein participates in key pathways such as the ubiquitin-proteasome pathway and the NF-κB signaling pathway. Its involvement in these pathways highlights its role in protein homeostasis and immune regulation within cells. The ubiquitin-proteasome pathway relies on several other proteins including ubiquitin itself and E3 ligases which tag proteins for degradation. PSMB2 collaborates with similar subunits to execute regulated protein breakdown ensuring proper cell function and adaptive responses to cellular stress.

PSMB2's dysregulation associates with conditions such as multiple myeloma and certain neurodegenerative disorders like Alzheimer's disease. In multiple myeloma alterations in PSMB2 expression contribute to the enhanced survival of malignant cells which may involve interactions with other proteasome inhibitors like MG132. This connection highlights potential therapeutic avenues targeting proteasome components to ameliorate disease symptoms and progression. In Alzheimer's disease PSMB2 may intertwine with amyloid precursor protein processing influencing pathogenic protein aggregation and neuronal damage.

产品实验方案

文献 (55)

Recent publications for all applications. Explore the full list and refine your search

Discover oncology 16:260 PubMed40025303

2025

Mechanistic insights into Uc001kfo-induced hepatocellular carcinoma metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Yanfeng Pan,Qin Liu,Qingqing Li,Zhenjun Ren

Scientific reports 15:1330 PubMed39779794

2025

The E3 ubiquitin ligase MARCH1 mediates downregulation of plasma membrane GABA receptors under ischemic conditions by inhibiting fast receptor recycling.

Applications

Unspecified application

Species

Unspecified reactive species

Musadiq A Bhat,Mohammad Hleihil,Irene Mondéjar,Thomas Grampp,Dietmar Benke

The Journal of biological chemistry 301:108134 PubMed39725038

2024

SETD7 promotes LC3B methylation and degradation in ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ziwei Zhang,Mingyang Li,Yanan Hou,Ting Huang,Bowen Zhang,Qiong Lin,Genbao Shao

iScience 27:111162 PubMed39569378

2024

Modulation of stress granule dynamics by phosphorylation and ubiquitination in plants.

Applications

Unspecified application

Species

Unspecified reactive species

Siou-Luan He,Xiling Wang,Sung-Il Kim,Liang Kong,Ailing Liu,Lei Wang,Ying Wang,Libo Shan,Ping He,Jyan-Chyun Jang

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38:e70135 PubMed39467145

2024

Retinal G-protein-coupled receptor deletion exacerbates AMD-like changes via the PINK1-parkin pathway under oxidative stress.

Applications

Unspecified application

Species

Unspecified reactive species

Yue Guo,Sitong Chen,Wenxue Guan,Ningda Xu,Li Zhu,Wei Du,Zhiming Liu,Henry K W Fong,Lvzhen Huang,Mingwei Zhao

Ophthalmic research 67:611-624 PubMed39406195

2024

Splice Variant of Retinal G-Protein-Coupled Receptor Deletion-Mediated Dysregulation of Autophagy Increases the Susceptibility to Age-Related Macular Degeneration-Like Defects.

Applications

Unspecified application

Species

Unspecified reactive species

Yue Guo,Ningda Xu,Huichao Yan,Jiarui Li,Lvzhen Huang,Li Zhu,Wei Du,Zhiming Liu,Mingwei Zhao

Journal of cell science 137: PubMed39140134

2024

Hominini-specific regulation of the cell cycle by stop codon readthrough of FEM1B.

Applications

Unspecified application

Species

Unspecified reactive species

Md Noor Akhtar,Anumeha Singh,Lekha E Manjunath,Dhruba Dey,Sangeetha Devi Kumar,Kirtana Vasu,Arpan Das,Sandeep M Eswarappa

The Journal of biological chemistry 300:107672 PubMed39128723

2024

USP7 deubiquitinates epigenetic reader ZMYND8 to promote breast cancer cell migration and invasion.

Applications

Unspecified application

Species

Unspecified reactive species

Kexin Tang,Tingting Yin,Bo Deng,Min Wang,Zixuan Ren,Shuo Wang,Xiong Liu,Huiyan Li,Jingjing Wang,Yating Du,Jun Zhou,Yan Chen,Yijie Wang

The Journal of biological chemistry 300:107463 PubMed38876304

2024

USP36 inhibits apoptosis by deubiquitinating cIAP1 and survivin in colorectal cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Bao Gao,Yuan Qiao,Shan Zhu,Ning Yang,Shan-Shan Zou,Yong-Jun Liu,Jingtao Chen

PLoS pathogens 20:e1011998 PubMed38530845

2024

Differential carbonic anhydrase activities control EBV-induced B-cell transformation and lytic cycle reactivation.

Applications

Unspecified application

Species

Unspecified reactive species

Samaresh Malik,Joyanta Biswas,Purandar Sarkar,Subhadeep Nag,Chandrima Gain,Shatadru Ghosh Roy,Bireswar Bhattacharya,Dipanjan Ghosh,Abhik Saha
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com